Prevalence, Antimicrobial Resistance, and Risk Factors of Enteric Bacterial Infections Among Children Under Five in Nairobi County, Kenya
International Journal of Microbiology · 2025-01 · 2025 (1)
DOI: 10.1155/ijm/6093453 ↗Abstract
Background Diarrheal disease remains a major cause of morbidity and mortality in children under 5 years, with the highest burden in sub‐Saharan Africa. This study investigated the bacterial etiology, antimicrobial resistance (AMR), and risk factors in childhood diarrhea in Nairobi, Kenya. Methods A cross‐sectional study was conducted among 216 children aged 0–60 months presenting with diarrhea at hospitals in Nairobi County. Stool samples were cultured and isolates tested against eight antibiotics. Caregiver questionnaires assessed risk factors. Associations were evaluated using Fisher′s exact test and odds ratios (ORs) were calculated to determine effect sizes. Results A total of 204 bacterial isolates were recovered. Escherichia coli was the most frequent (38.2%), followed by Shigella sonnei (11.8%) and Enterobacter cloacae (9.8%). The overall prevalence of enteric bacterial infection was 94.4%. Key risk factors significantly associated with infection included the absence of consistent soap availability (OR: 7.4, 95% CI: 3.7–15.0), visible poor sanitation (OR: 4.8, 95% CI: 1.7–13.8), and lack of safe drinking water (OR: 12.9, 95% CI: 1.7–98.9). AMR was widespread, with 82.8% of isolates resistant to at least one antibiotic and 58.3% classified as multidrug‐resistant (MDR). High resistance to ampicillin and amoxicillin–clavulanic acid was common, exceeding 70% in key pathogens like E. coli and E. cloacae . In contrast, meropenem, amikacin, gentamicin, and ciprofloxacin retained near‐complete efficacy. Conclusion Childhood diarrhea in Nairobi is predominantly bacterial, driven by diverse pathogens and exacerbated by poor hygiene and alarmingly high AMR. Urgent integrated interventions are needed, including strengthening WASH infrastructure, promoting rational antibiotic use, and enhancing AMR surveillance. These findings provide a critical baseline for public health action and underscore the need to safeguard last‐line antibiotics.
EUVIMED